entertainment -WSS

entertainment

author：hotspot 2025-10-02 22:41:05 - browse：92

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： The PBM ad wars are taking over Washington, D.C.

leisure time

WSS

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

How to keep neuroscience’s past racism from being its future

Can sheer will power keep patients alive in their dying hours?

Why health care costs have stayed mostly flat since 2010

How corporate America is slashing DEI workers amid backlash to diversity programs

North Korean leader's powerful sister says warplanes repelled US spy plane

explore

entertainment

entertainment

Virginia high school admissions case could be legal follow

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

The high cost of giving birth even with insurance

In Spain, a hospital brews its own CAR

Anesthesiologist group: stop taking Ozempic before surgery

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Novavax promises a turnaround & Lilly roils the obesity market

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

The high cost of giving birth even with insurance

Hospitals owned by private equity see complications spike 25%

Wikipedia

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Hospitals owned by private equity see complications spike 25%

Another man arrested in connection with shooting at Kansas nightclub

What are cluster munitions? Biden defends decision to send controversial weapons to Ukraine

CRISPR gene editing developments we’re watching in 2024

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

focus

leisure time

focus

explore